Marks Peter Ashley
Director
Buy
Calculated transaction value
$23.81K
47,620 shares @ $0.5
Traded
Aug 31, 2026
Filed
Sep 8, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Alterity Therapeutics Ltd
ATHE
Transactions reported in official disclosures
5 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Marks Peter Ashley Director | Sep 8, 2026 8-day lag | Buy Aug 31, 2026 | $23.81K Filed shares x price | SEC Form 4 View filing | |
| Marks Peter Ashley Director | Sep 8, 2026 8-day lag | Buy Aug 31, 2026 | $23.81K Filed shares x price | SEC Form 4 View filing | |
| Stamler David Allen Chief Executive Officer | Sep 8, 2026 8-day lag | Buy Aug 31, 2026 | $23.81K Filed shares x price | SEC Form 4 View filing | |
| Gozlan Lawrence Bernard Director | Jun 23, 2026 8-day lag | Award Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Babarczy Julian Michael Director | Jun 23, 2026 8-day lag | Award Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Marks Peter Ashley
Director
Buy
Calculated transaction value
$23.81K
47,620 shares @ $0.5
Traded
Aug 31, 2026
Filed
Sep 8, 2026
Stamler David Allen
Chief Executive Officer
Buy
Calculated transaction value
$23.81K
47,620 shares @ $0.5
Traded
Aug 31, 2026
Filed
Sep 8, 2026
Gozlan Lawrence Bernard
Director
Award
Calculated transaction value
$0
1,000,000 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 23, 2026
Babarczy Julian Michael
Director
Award
Calculated transaction value
$0
2,000,000 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 23, 2026